Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, Week Ending July 12, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Jazz Pharmaceuticals plc Preclinical Pan-RAF inhibitor program $3,500,000 Altimmune Inc. Spitfire Pharma, Inc. $5,000,000 eHealth Acquirer Target Price iMedX, Inc. Prevalent, Inc. and Axcension, Inc. N/A Waystar Digitize.AI N/A Rhapsody... Read More »
Q2:19 Posts Strong Healthcare Deal Volume & Dollars
Second quarter deal volume was robust, based on preliminary results. Some 424 deals are on the books for the quarter, representing an 8% increase over the first quarter (394 deals). It’s still a hard comparison with Q2:18 numbers, which had 484 announcements, 12% higher than this year’s period. Spending remained high in the second quarter, at $138.5 billion, thanks to AbbVie’s (NYSE: ABBV) $87 billion deal for Allergan (NYSE: AGN) announced in late June. Coincidentally, even higher totals were posted in the first quarter and in the second quarter of 2018, also due to mega-deals. In this year’s first quarter, Bristol-Myers Squibb’s (NYSE: BMY) $74 billion deal for Celgene (NASDAQ: CELG) and... Read More »
June Healthcare M&A Busted Out All Over
Healthcare mergers and acquisitions turned in another strong performance in June, on the heels of a busy month in May. Preliminary data shows 138 transactions announced, just 5% below the previous month’s 146 and 7% behind the same month in 2018. The Long-Term Care sector led the way, as usual, with a 23% share of the month’s total deal volume. With 32 deals reported, deal activity wasn’t as strong as it was in May (42 deals), but stayed on par with the 31 deals announced the year before. Two sectors posted big gains, year over year. The Laboratories, MRI & Dialysis sector saw a 600% increase, albeit on only seven deals. The Medical Device sector realized a 56% jump over last year’s... Read More »
Health Care M&A Deals, Week Ending July 5, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Zai Lab Limited License for INCMGA0012 $17,500,000 eHealth Acquirer Target Price Carenet Healthcare Services Telehealth subsidiary of Citra Health N/A Net Health Optima Healthcare Solutions N/A Physician Medical Groups Acquirer Target... Read More »
Health Care M&A Deals, Week Ending June 28, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Gilead Sciences, Inc. Rights to immunoncology target inhibitors $20,000,000 eHealth Acquirer Target Price CentralReach Pathfinder Health Innovations N/A Thomas H. Lee Partners, L.P. Nextech Systems N/A The Jordan Company Vyne N/A Home Health Care & Hospice Acquirer Target... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
